sp1 tafii130 transcriptional activity disrupted early huntingtons disease
huntingtons disease hd inherited neurodegenerative disease caused expansion polyglutamine tract huntingtin protein transcriptional dysregulation implicated hd pathogenesis report huntingtin interacts transcriptional activator sp1 coactivator tafii130 coexpression sp1 tafii130 cultured striatal cells wild-type hd transgenic mice reverses transcriptional inhibition dopamine d2 receptor gene caused mutant huntingtin well protects neurons huntingtin-induced cellular toxicity furthermore soluble mutant huntingtin inhibits sp1 binding dna postmortem brain tissues presymptomatic affected hd patients understanding early molecular events hd may provide opportunity interfere effects mutant huntingtin development disease symptoms
